Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 11/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.36 |
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CCR2 | P41597 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22900526 | 0.92 | QPCT (0.54) | QPCTKDM4EALDH1A1HPGD | |
| SCHEMBL22900682 | 0.89 | QPCT (0.56) | QPCTKDM4EALDH1A1HPGDGAA | |
| SCHEMBL22900287 | 0.83 | QPCT (0.58) | QPCT | |
| SCHEMBL22900288 | 0.83 | QPCT (0.52) | QPCT | |
| SCHEMBL22900255 | 0.82 | QPCT (0.54) | QPCTKDM4EALDH1A1HPGDGAA | |
| SCHEMBL22900243 | 0.82 | QPCT (0.51) | QPCT | |
| SCHEMBL22900167 | 0.81 | QPCT (0.54) | QPCT | |
| SCHEMBL22900251 | 0.81 | QPCT (0.54) | QPCT | |
| SCHEMBL22900208 | 0.81 | QPCT (0.54) | QPCT | |
| SCHEMBL22900596 | 0.81 | QPCT (0.55) | QPCT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021009068-A1 | N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME | SCENIC IMMUNOLOGY B.V. (NL) | 2021-01-21 | — | — | WO | disclosed |